Variability in mutational fitness effects prevents full lethal transitions in large quasispecies populations

[EN] The distribution of mutational fitness effects (DMFE) is crucial to the evolutionary fate of quasispecies. In this article we analyze the effect of the DMFE on the dynamics of a large quasispecies by means of a phenotypic version of the classic Eigen's model that incorporates beneficia...

Descripción completa

Detalles Bibliográficos
Autores: Sardanyes Cayuela, Jose, Simó, Carles, Martínez, Regina, Solé, Ricard V., Elena Fito, Santiago Fco
Tipo de recurso: artículo
Fecha de publicación:2014
País:España
Institución:Universitat Politècnica de València (UPV)
Repositorio:RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Idioma:inglés
OAI Identifier:oai:riunet.upv.es:10251/81389
Acceso en línea:https://riunet.upv.es/handle/10251/81389
Access Level:acceso abierto
Palabra clave:Single-nucleotide substitutions
Immunodeficiency-virus type-1
Vesicular stomatitis-virus
Tobacco-ETCH-virus
Error threshold
RNA virus
Deleterious mutations
Muller ratchet
Human cancers
Evolution
Descripción
Sumario:[EN] The distribution of mutational fitness effects (DMFE) is crucial to the evolutionary fate of quasispecies. In this article we analyze the effect of the DMFE on the dynamics of a large quasispecies by means of a phenotypic version of the classic Eigen's model that incorporates beneficial, neutral, deleterious, and lethal mutations. By parameterizing the model with available experimental data on the DMFE of Vesicular stomatitis virus (VSV) and Tobacco etch virus (TEV), we found that increasing mutation does not totally push the entire viral quasispecies towards deleterious or lethal regions of the phenotypic sequence space. The probability of finding regions in the parameter space of the general model that results in a quasispecies only composed by lethal phenotypes is extremely small at equilibrium and in transient times. The implications of our findings can be extended to other scenarios, such as lethal mutagenesis or genomically unstable cancer, where increased mutagenesis has been suggested as a potential therapy.